AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
Unlock the market timeline & signal feed
898 signals in the last 90 days.
The order this company entered each market — oldest to newest
Sr. Professional Medical Representative
Senior Clinical Research Associate
Sign up to see the full signal feed
How AbbVie's international expansion compares to its competitors
AbbVieYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 AbbVieYou | 58 | 1 | +72% | 843 | 35 |
Scaling fast — 1,939 roles opened in the last 90 days, up 101% vs the prior period. Engineering-led and concentrated in United States.
Beijing, Beijing, China · yesterday
Sr. Professional Medical Representative
Hangzhou-Shaoxing Metropolitan Area · yesterday
Sr. Professional Medical Representative
Zwolle, Overijssel, Netherlands · yesterday
Quality Assurance Officer
47 technologies detected across the stack.
No campaigns running in this window.
57 mentions in the last 90 days.
Parexel executives led three panel discussions at DPHARM 2026 in Boston, focusing on enterprise AI innovation, future talent development, and patient-centric drug development. ParexelAI suite has reduced site screening time by 50% and medical writing time by 30%.
AbbVie participated in the 24th Annual Global Healthcare Conference hosted by Morgan Stanley.
Keeps BioPharma received Phase 2 IND approval for Idetrexed, a FRα-targeted cancer therapy, to treat platinum-resistant ovarian cancer in 50 patients, showing 36% ORR in Phase 1.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about AbbVie's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
